We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

153 hedge funds and large institutions have $539M invested in NEVRO CORP. in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 54 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 20

9% more funds holding

Funds holding: 140153 (+13)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 54

35% less capital invested

Capital invested by funds: $834M → $539M (-$296M)

91% less call options, than puts

Call options by funds: $1.26M | Put options by funds: $14.2M

Holders
153
Holders Change
+13
Holders Change %
+9.29%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
34
Increased
48
Reduced
54
Closed
20
Calls
$1.26M
Puts
$14.2M
Net Calls
-$13M
Net Calls Change
-$6.32M
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
51
TD Capital Management
Tennessee
$1.22M
JF
52
Jump Financial
Illinois
$1.18M +$670K +40,501 +98%
HF
53
HRT Financial
New York
$1.16M +$1.33M +80,508 New
CCIA
54
Campbell & Co Investment Adviser
Maryland
$985K +$1.13M +68,182 New
Swiss National Bank
55
Swiss National Bank
Switzerland
$930K -$112K -6,800 -10%
Voloridge Investment Management
56
Voloridge Investment Management
Florida
$901K -$3.16M -190,917 -75%
SCM
57
Semanteon Capital Management
Massachusetts
$885K +$151K +9,136 +18%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$811K +$20.3K +1,229 +2%
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
$795K +$759K +45,904 New
Invesco
60
Invesco
Georgia
$784K -$14.7M -888,201 -94%
Balyasny Asset Management
61
Balyasny Asset Management
Illinois
$773K -$9.96M -602,297 -92%
William Blair & Company
62
William Blair & Company
Illinois
$753K +$227K +13,750 +36%
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
$745K +$558K +33,760 +189%
HSBC Holdings
64
HSBC Holdings
United Kingdom
$661K +$512K +30,993 +209%
T. Rowe Price Associates
65
T. Rowe Price Associates
Maryland
$651K +$116K +7,004 +18%
M&T Bank
66
M&T Bank
New York
$590K +$4.26K +258 +0.6%
UBS Group
67
UBS Group
Switzerland
$563K +$501K +30,307 +348%
UBS AM
68
UBS AM
Illinois
$563K
Legal & General Group
69
Legal & General Group
United Kingdom
$533K
AllianceBernstein
70
AllianceBernstein
Tennessee
$530K -$74.4K -4,500 -11%
PAM
71
Panagora Asset Management
Massachusetts
$530K -$690K -41,729 -53%
Walleye Capital
72
Walleye Capital
New York
$497K +$233K +14,086 +69%
Mirae Asset Global Investments
73
Mirae Asset Global Investments
South Korea
$495K
Truist Financial
74
Truist Financial
North Carolina
$483K -$83.3K -5,038 -13%
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$476K -$83.5K -5,051 -13%

NVRO Hedge Fund Activity: Q1 2024 in Review

153 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2024, worth a combined $539M — down 35% from $834M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NVRO positions and 20 closed out — a net gain of 14 holders — while 48 added to existing stakes and 54 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $13.1M. The largest seller was Fidelity Investments, cutting an estimated $17.9M.

  • 153 institutional investors held NEVRO CORP. (NVRO) as of Q1 2024, up from 140 in Q4 2023.
  • Funds reported $539M of NEVRO CORP. stock for Q1 2024, down 35% quarter-over-quarter.
  • 34 funds opened new NEVRO CORP. positions in Q1 2024 and 20 closed out, a net change of +14 holders.
  • The largest NEVRO CORP. buyer in Q1 2024 was Citadel Advisors, an estimated $13.1M added.
  • The largest NEVRO CORP. seller in Q1 2024 was Fidelity Investments, an estimated $17.9M sold.

Based on aggregated 13F filings for Q1 2024.